Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones

To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis. Different rat pancreases were morphometrically analyzed afte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pancreas 2010-11, Vol.39 (8), p.1167-1172
Hauptverfasser: Jörns, Anne, Sennholz, Christoph, Naujok, Ortwin, Lenzen, Sigurd
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1172
container_issue 8
container_start_page 1167
container_title Pancreas
container_volume 39
creator Jörns, Anne
Sennholz, Christoph
Naujok, Ortwin
Lenzen, Sigurd
description To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis. Different rat pancreases were morphometrically analyzed after immunohistochemical staining for markers of proliferation and apoptosis. Hydrocortisone increased the beta cell mass of rat pancreases through an increase of proliferation. This effect was counteracted by an increase of apoptosis. In contrast, thyroxine decreased the beta cell mass through an increase of apoptosis. This effect was counteracted by an increased rate of proliferation. Combined treatment with both hormones nullified the antagonistic effects on proliferation, apoptosis, and beta cell mass, thereby contributing to the maintenance of a stable total beta cell volume of the pancreas. Hydrocortisone and thyroxine induced analogous changes in pancreatic duct cells, which represent a crucial pool for new beta cells through neogenesis. This may explain the positive effects of glucocorticoids in the immunosuppressive therapy regimen after whole pancreas transplantation upon long-term insulin independence, which is not achievable with isolated islets because of the loss of duct cells during the islet process before transplantation.
doi_str_mv 10.1097/MPA.0b013e3181dfce4f
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_758838806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>758838806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-4746a766779f4a307e9ca094a02f2fa30c7452258bbf265542f352ad9eb9df643</originalsourceid><addsrcrecordid>eNpdkMtOwzAQRS0EoqXwBwh5xyrF78eyIF5SESxgwyZyHLsNSuJiO4v-PalaWLAazZ17ZzQHgEuM5hhpefPytpijCmHqKFa49tYxfwSmmFNRMEXUMZgipXhBsZQTcJbSF0JYUq5PwYQgoSjBego-b1020Lq2hZ1JCUa3GlqTm9DDpod57WA0GW5Mb6MzaRRiGFZruGoHG2yIubGhqRM0fT3OtnFs4DrELvQunYMTb9rkLg51Bj4e7t_vnorl6-Pz3WJZWCpJLphkwkghpNSeGYqk09YgzQwinvhRsJJxQriqKk8E54x4yomptat07QWjM3C937uJ4XtwKZddk3Yfmd6FIZWSK0WVQmJ0sr3TxpBSdL7cxKYzcVtiVO6gliPU8j_UMXZ1ODBUnav_Qr8U6Q-biXVx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>758838806</pqid></control><display><type>article</type><title>Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Jörns, Anne ; Sennholz, Christoph ; Naujok, Ortwin ; Lenzen, Sigurd</creator><creatorcontrib>Jörns, Anne ; Sennholz, Christoph ; Naujok, Ortwin ; Lenzen, Sigurd</creatorcontrib><description>To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis. Different rat pancreases were morphometrically analyzed after immunohistochemical staining for markers of proliferation and apoptosis. Hydrocortisone increased the beta cell mass of rat pancreases through an increase of proliferation. This effect was counteracted by an increase of apoptosis. In contrast, thyroxine decreased the beta cell mass through an increase of apoptosis. This effect was counteracted by an increased rate of proliferation. Combined treatment with both hormones nullified the antagonistic effects on proliferation, apoptosis, and beta cell mass, thereby contributing to the maintenance of a stable total beta cell volume of the pancreas. Hydrocortisone and thyroxine induced analogous changes in pancreatic duct cells, which represent a crucial pool for new beta cells through neogenesis. This may explain the positive effects of glucocorticoids in the immunosuppressive therapy regimen after whole pancreas transplantation upon long-term insulin independence, which is not achievable with isolated islets because of the loss of duct cells during the islet process before transplantation.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/MPA.0b013e3181dfce4f</identifier><identifier>PMID: 20683219</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Apoptosis - drug effects ; Bromodeoxyuridine - metabolism ; Cell Count ; Cell Proliferation - drug effects ; Glucocorticoids - pharmacology ; Homeodomain Proteins - metabolism ; Hydrocortisone - pharmacology ; Immunohistochemistry ; In Situ Nick-End Labeling ; Insulin-Secreting Cells - cytology ; Insulin-Secreting Cells - drug effects ; Insulin-Secreting Cells - metabolism ; Pancreatic Ducts - cytology ; Pancreatic Ducts - drug effects ; Pancreatic Ducts - metabolism ; Rats ; Rats, Inbred Lew ; Thyroid Hormones - pharmacology ; Thyroxine - pharmacology ; Trans-Activators - metabolism</subject><ispartof>Pancreas, 2010-11, Vol.39 (8), p.1167-1172</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-4746a766779f4a307e9ca094a02f2fa30c7452258bbf265542f352ad9eb9df643</citedby><cites>FETCH-LOGICAL-c372t-4746a766779f4a307e9ca094a02f2fa30c7452258bbf265542f352ad9eb9df643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20683219$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jörns, Anne</creatorcontrib><creatorcontrib>Sennholz, Christoph</creatorcontrib><creatorcontrib>Naujok, Ortwin</creatorcontrib><creatorcontrib>Lenzen, Sigurd</creatorcontrib><title>Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis. Different rat pancreases were morphometrically analyzed after immunohistochemical staining for markers of proliferation and apoptosis. Hydrocortisone increased the beta cell mass of rat pancreases through an increase of proliferation. This effect was counteracted by an increase of apoptosis. In contrast, thyroxine decreased the beta cell mass through an increase of apoptosis. This effect was counteracted by an increased rate of proliferation. Combined treatment with both hormones nullified the antagonistic effects on proliferation, apoptosis, and beta cell mass, thereby contributing to the maintenance of a stable total beta cell volume of the pancreas. Hydrocortisone and thyroxine induced analogous changes in pancreatic duct cells, which represent a crucial pool for new beta cells through neogenesis. This may explain the positive effects of glucocorticoids in the immunosuppressive therapy regimen after whole pancreas transplantation upon long-term insulin independence, which is not achievable with isolated islets because of the loss of duct cells during the islet process before transplantation.</description><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Bromodeoxyuridine - metabolism</subject><subject>Cell Count</subject><subject>Cell Proliferation - drug effects</subject><subject>Glucocorticoids - pharmacology</subject><subject>Homeodomain Proteins - metabolism</subject><subject>Hydrocortisone - pharmacology</subject><subject>Immunohistochemistry</subject><subject>In Situ Nick-End Labeling</subject><subject>Insulin-Secreting Cells - cytology</subject><subject>Insulin-Secreting Cells - drug effects</subject><subject>Insulin-Secreting Cells - metabolism</subject><subject>Pancreatic Ducts - cytology</subject><subject>Pancreatic Ducts - drug effects</subject><subject>Pancreatic Ducts - metabolism</subject><subject>Rats</subject><subject>Rats, Inbred Lew</subject><subject>Thyroid Hormones - pharmacology</subject><subject>Thyroxine - pharmacology</subject><subject>Trans-Activators - metabolism</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkMtOwzAQRS0EoqXwBwh5xyrF78eyIF5SESxgwyZyHLsNSuJiO4v-PalaWLAazZ17ZzQHgEuM5hhpefPytpijCmHqKFa49tYxfwSmmFNRMEXUMZgipXhBsZQTcJbSF0JYUq5PwYQgoSjBego-b1020Lq2hZ1JCUa3GlqTm9DDpod57WA0GW5Mb6MzaRRiGFZruGoHG2yIubGhqRM0fT3OtnFs4DrELvQunYMTb9rkLg51Bj4e7t_vnorl6-Pz3WJZWCpJLphkwkghpNSeGYqk09YgzQwinvhRsJJxQriqKk8E54x4yomptat07QWjM3C937uJ4XtwKZddk3Yfmd6FIZWSK0WVQmJ0sr3TxpBSdL7cxKYzcVtiVO6gliPU8j_UMXZ1ODBUnav_Qr8U6Q-biXVx</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Jörns, Anne</creator><creator>Sennholz, Christoph</creator><creator>Naujok, Ortwin</creator><creator>Lenzen, Sigurd</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201011</creationdate><title>Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones</title><author>Jörns, Anne ; Sennholz, Christoph ; Naujok, Ortwin ; Lenzen, Sigurd</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-4746a766779f4a307e9ca094a02f2fa30c7452258bbf265542f352ad9eb9df643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Bromodeoxyuridine - metabolism</topic><topic>Cell Count</topic><topic>Cell Proliferation - drug effects</topic><topic>Glucocorticoids - pharmacology</topic><topic>Homeodomain Proteins - metabolism</topic><topic>Hydrocortisone - pharmacology</topic><topic>Immunohistochemistry</topic><topic>In Situ Nick-End Labeling</topic><topic>Insulin-Secreting Cells - cytology</topic><topic>Insulin-Secreting Cells - drug effects</topic><topic>Insulin-Secreting Cells - metabolism</topic><topic>Pancreatic Ducts - cytology</topic><topic>Pancreatic Ducts - drug effects</topic><topic>Pancreatic Ducts - metabolism</topic><topic>Rats</topic><topic>Rats, Inbred Lew</topic><topic>Thyroid Hormones - pharmacology</topic><topic>Thyroxine - pharmacology</topic><topic>Trans-Activators - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jörns, Anne</creatorcontrib><creatorcontrib>Sennholz, Christoph</creatorcontrib><creatorcontrib>Naujok, Ortwin</creatorcontrib><creatorcontrib>Lenzen, Sigurd</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jörns, Anne</au><au>Sennholz, Christoph</au><au>Naujok, Ortwin</au><au>Lenzen, Sigurd</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>2010-11</date><risdate>2010</risdate><volume>39</volume><issue>8</issue><spage>1167</spage><epage>1172</epage><pages>1167-1172</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><abstract>To compare the effects of glucocorticoids and thyroid hormones on the regulation of the beta cell mass in the pancreas, the rats were treated and analyzed for cell cycle changes in islet and duct cells as a source for beta cell neogenesis. Different rat pancreases were morphometrically analyzed after immunohistochemical staining for markers of proliferation and apoptosis. Hydrocortisone increased the beta cell mass of rat pancreases through an increase of proliferation. This effect was counteracted by an increase of apoptosis. In contrast, thyroxine decreased the beta cell mass through an increase of apoptosis. This effect was counteracted by an increased rate of proliferation. Combined treatment with both hormones nullified the antagonistic effects on proliferation, apoptosis, and beta cell mass, thereby contributing to the maintenance of a stable total beta cell volume of the pancreas. Hydrocortisone and thyroxine induced analogous changes in pancreatic duct cells, which represent a crucial pool for new beta cells through neogenesis. This may explain the positive effects of glucocorticoids in the immunosuppressive therapy regimen after whole pancreas transplantation upon long-term insulin independence, which is not achievable with isolated islets because of the loss of duct cells during the islet process before transplantation.</abstract><cop>United States</cop><pmid>20683219</pmid><doi>10.1097/MPA.0b013e3181dfce4f</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-3177
ispartof Pancreas, 2010-11, Vol.39 (8), p.1167-1172
issn 0885-3177
1536-4828
language eng
recordid cdi_proquest_miscellaneous_758838806
source MEDLINE; Journals@Ovid Complete
subjects Animals
Apoptosis - drug effects
Bromodeoxyuridine - metabolism
Cell Count
Cell Proliferation - drug effects
Glucocorticoids - pharmacology
Homeodomain Proteins - metabolism
Hydrocortisone - pharmacology
Immunohistochemistry
In Situ Nick-End Labeling
Insulin-Secreting Cells - cytology
Insulin-Secreting Cells - drug effects
Insulin-Secreting Cells - metabolism
Pancreatic Ducts - cytology
Pancreatic Ducts - drug effects
Pancreatic Ducts - metabolism
Rats
Rats, Inbred Lew
Thyroid Hormones - pharmacology
Thyroxine - pharmacology
Trans-Activators - metabolism
title Beta cell mass regulation in the rat pancreas through glucocorticoids and thyroid hormones
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A48%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beta%20cell%20mass%20regulation%20in%20the%20rat%20pancreas%20through%20glucocorticoids%20and%20thyroid%20hormones&rft.jtitle=Pancreas&rft.au=J%C3%B6rns,%20Anne&rft.date=2010-11&rft.volume=39&rft.issue=8&rft.spage=1167&rft.epage=1172&rft.pages=1167-1172&rft.issn=0885-3177&rft.eissn=1536-4828&rft_id=info:doi/10.1097/MPA.0b013e3181dfce4f&rft_dat=%3Cproquest_cross%3E758838806%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=758838806&rft_id=info:pmid/20683219&rfr_iscdi=true